OPKO Health Total Assets 2012-2025 | OPK

OPKO Health total assets from 2012 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
OPKO Health Annual Total Assets
(Millions of US $)
2024 $2,200
2023 $2,012
2022 $2,167
2021 $2,400
2020 $2,473
2019 $2,309
2018 $2,451
2017 $2,590
2016 $2,767
2015 $2,799
2014 $1,268
2013 $1,392
2012 $290
2011 $229
OPKO Health Quarterly Total Assets
(Millions of US $)
2025-09-30 $1,996
2025-06-30 $1,973
2025-03-31 $2,128
2024-12-31 $2,200
2024-09-30 $2,256
2024-06-30 $1,980
2024-03-31 $1,974
2023-12-31 $2,012
2023-09-30 $2,057
2023-06-30 $2,159
2023-03-31 $2,170
2022-12-31 $2,167
2022-09-30 $2,225
2022-06-30 $2,370
2022-03-31 $2,307
2021-12-31 $2,400
2021-09-30 $2,418
2021-06-30 $2,422
2021-03-31 $2,520
2020-12-31 $2,473
2020-09-30 $2,371
2020-06-30 $2,324
2020-03-31 $2,233
2019-12-31 $2,309
2019-09-30 $2,370
2019-06-30 $2,456
2019-03-31 $2,575
2018-12-31 $2,451
2018-09-30 $2,481
2018-06-30 $2,531
2018-03-31 $2,579
2017-12-31 $2,590
2017-09-30 $2,722
2017-06-30 $2,769
2017-03-31 $2,760
2016-12-31 $2,767
2016-09-30 $2,800
2016-06-30 $2,774
2016-03-31 $2,793
2015-12-31 $2,799
2015-09-30 $3,016
2015-06-30 $1,525
2015-03-31 $1,512
2014-12-31 $1,268
2014-09-30 $1,295
2014-06-30 $1,327
2014-03-31 $1,356
2013-12-31 $1,392
2013-09-30 $1,383
2013-06-30 $641
2013-03-31 $654
2012-12-31 $290
2012-09-30 $250
2012-06-30 $230
2012-03-31 $232
2011-12-31 $229
2011-09-30 $151
2011-06-30 $160
2011-03-31 $176
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.952B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $203.946B 23.74
Intuitive Surgical (ISRG) United States $173.357B 66.87
IDEXX Laboratories (IDXX) United States $51.473B 49.32
Edwards Lifesciences (EW) United States $45.675B 30.63
Alcon (ALC) Switzerland $38.991B 26.28
IQVIA Holdings (IQV) United States $31.930B 17.25
Mettler-Toledo (MTD) United States $28.060B 32.10
DexCom (DXCM) United States $27.289B 37.62
STERIS (STE) Ireland $24.749B 25.02
Waters (WAT) United States $22.705B 30.02
Coloplast (CLPBY) Denmark $17.601B 26.93
Hologic (HOLX) United States $16.701B 17.48
SONOVA HOLDING (SONVY) Switzerland $15.912B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $13.959B 11.58
Penumbra (PEN) United States $13.355B 93.94
Globus Medical (GMED) United States $11.752B 24.67
SARTORIUS (SSSGY) Germany $7.976B 46.32
Masimo (MASI) United States $7.474B 23.95
Glaukos (GKOS) United States $6.463B 0.00
Sysmex ADR (SSMXY) Japan $6.024B 19.14
Teleflex (TFX) United States $4.792B 7.64
TransMedics (TMDX) United States $4.616B 54.68
LivaNova (LIVN) United Kingdom $3.635B 19.63
Integer Holdings (ITGR) United States $3.029B 14.22
Veracyte (VCYT) United States $2.861B 32.60
Elekta AB (EKTAY) Sweden $2.241B 20.97
UFP Technologies (UFPT) United States $2.062B 27.22
Alphatec Holdings (ATEC) United States $2.053B 0.00
Artivion (AORT) United States $1.876B 86.07
Nihon Kohden (NHNKY) Japan $1.855B 20.47
AxoGen (AXGN) United States $1.611B 0.00
PROCEPT BioRobotics (PRCT) United States $1.606B 0.00
Pulse Biosciences (PLSE) United States $1.406B 0.00
Tandem Diabetes Care (TNDM) United States $1.300B 0.00
IRadimed (IRMD) United States $1.221B 58.16
Integra LifeSciences Holdings (IART) United States $0.877B 4.75
AVANOS MEDICAL, INC (AVNS) United States $0.677B 13.51
SiBone (SIBN) United States $0.676B 0.00
Tactile Systems Technology (TCMD) United States $0.623B 36.25
Alpha Tau Medical (DRTS) Israel $0.603B 0.00
Beta Bionics (BBNX) United States $0.576B 0.00
Pacific Biosciences Of California (PACB) United States $0.549B 0.00
NeuroPace (NPCE) United States $0.522B 0.00
Mesa Laboratories (MLAB) United States $0.515B 13.42
ORTHOFIX MEDICAL INC (OFIX) United States $0.507B 0.00
AngioDynamics (ANGO) United States $0.435B 0.00
OrthoPediatrics (KIDS) United States $0.418B 0.00
ClearPoint Neuro (CLPT) United States $0.383B 0.00
RxSight (RXST) United States $0.345B 0.00
Delcath Systems (DCTH) United States $0.331B 55.12
Semler Scientific (SMLR) United States $0.311B 2.32
Sight Sciences (SGHT) United States $0.310B 0.00
Spectral Diagnostics (EDTXF) Canada $0.283B 0.00
908 Devices (MASS) United States $0.237B 0.00
Anteris Technologies Global (AVR) Australia $0.226B 0.00
EDAP TMS S.A (EDAP) France $0.177B 0.00
CVRx (CVRX) United States $0.172B 0.00
Rapid Micro Biosystems (RPID) United States $0.172B 0.00
Lucid Diagnostics (LUCD) United States $0.168B 0.00
Nano-X Imaging (NNOX) Israel $0.160B 0.00
Inogen (INGN) United States $0.154B 0.00
LENSAR (LNSR) United States $0.144B 0.00
Treace Medical Concepts (TMCI) United States $0.144B 0.00
Microbot Medical (MBOT) United States $0.118B 0.00
Zomedica (ZOMDF) United States $0.118B 0.00
Hyperfine (HYPR) United States $0.107B 0.00
Neuronetics (STIM) United States $0.107B 0.00
Solana (HSDT) United States $0.090B 0.00
Sensus Healthcare (SRTS) United States $0.083B 0.00
QT Imaging Holdings (QTIH) United States $0.078B 0.00
InspireMD (NSPR) United States $0.074B 0.00
Accuray (ARAY) United States $0.070B 0.00
DarioHealth (DRIO) United States $0.067B 0.00
QT Imaging Holdings (QTI) United States $0.060B 0.00
Positron (POSC) United States $0.058B 0.00
Spectral AI (MDAI) United States $0.047B 0.00
Atossa Genetics (ATOS) United States $0.046B 0.00
Precision Optics (POCI) United States $0.044B 0.00
Ekso Bionics Holdings (EKSO) United States $0.027B 0.00
Baird Medical Investment Holdings (BDMD) $0.024B 0.00
Adagio Medical Holdings (ADGM) United States $0.015B 0.00
Envoy Medical (COCH) United States $0.014B 0.00
Vicarious Surgical (RBOT) United States $0.013B 0.00
Check-Cap (MBAI) Israel $0.012B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
NexGel (NXGL) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
EnVVeno Medical (NVNO) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Nanovibronix (NAOV) United States $0.004B 0.00
ENvue Medical (FEED) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Autonomix Medical (AMIX) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
WORK Medical Technology Group (WOK) China $0.000B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00